Acadia Pharmaceuticals buy JPMorgan Chase & Co.
Start price
29.09.25
/
50%
€18.17
Target price
29.09.26
€28.15
Performance (%)
-0.91%
Price
20.05.26
€18.01
Summary
This prediction is currently active. Since the start of the prediction for Acadia Pharmaceuticals the price has only changed by -0.91%. This prediction currently runs until 29.09.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | -2.676% | -2.676% |
| iShares Core DAX® | 1,12 % | -1,55 % |
| iShares Nasdaq 100 | 0,35 % | 9,67 % |
| iShares Nikkei 225® | -1,41 % | 2,91 % |
| iShares S&P 500 | 0,54 % | 4,77 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals (NASDAQ:ACAD) had its price target lowered by analysts at JPMorgan Chase & Co. from $34.00 to $33.00. They now have an "overweight" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€19.87
04.03.26
04.03.26
€29.31
04.03.27
04.03.27
-11.20%
20.05.26
20.05.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.43
17.11.25
17.11.25
€26.71
17.11.26
17.11.26
-13.66%
20.05.26
20.05.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.00
24.07.25
24.07.25
€28.88
24.07.26
24.07.26
-9.98%
20.05.26
20.05.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€19.28
06.06.25
06.06.25
€26.22
06.06.26
06.06.26
-6.61%
20.05.26
20.05.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€16.50
25.03.24
25.03.24
€23.06
25.03.25
25.03.25
-4.67%
26.03.25
26.03.25